AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Add a description, image, and links to the crispr-design topic page so that developers can more easily learn about it.

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...

Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ... Dec. 13, 2024 — Microorganisms produce a wide variety of natural products that can be ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...

With AWS on board, ElevateBio says that it can design high-level CRISPR proteins with improved therapeutic potential both for partners and internal pipeline development. The company’s technology ...

Bacteria steal DNA from silent viruses and use it like a memory bank. That memory helps them protect future generations.